Maurer E, Neuhaus TJ, Weitz M, Kuehni CE, Laube GF. Paediatric end-stage renal disease and renal replacement therapy in Switzerland: survival and treatment trends over four decades. Swiss Med Wkly. 2020;150:w20300.
Largiadèr F, Leumann E. Nierentransplantation beim Kind. Helv Chir Acta. 1972;39(1):325–9.
Ambühl P. Aktuelle Erkenntnisse zur Schweizer Dialysepopulation. Hausarzt Praxis. 2017;12:22–6.
Pope JC, Brock JW, Adams MC, Stephen FD, Ichikawa I. Paradigm shift from classic anatomic theories to contemporary cell biological views of CAKUT. J Am Soc Nephrol. 1999;10:2018–28.
König J, Kranz B, König S, Schlingmann KP, Titieni A, Tönshoff B, et al.; Gesellschaft für Pädiatrische Nephrologie (GPN). Phenotypic spectrum of children with nephronophthisis and related ciliopathies. Clin J Am Soc Nephrol. 2017;12(12):1974–83. doi:.https://doi.org/10.2215/CJN.01280217
Warejko JK, Tan W, Daga A, Schapiro D, Lawson JA, Shril S, et al. Whole exome sequencing of patients with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2018;13(1):53–62. doi:.https://doi.org/10.2215/CJN.04120417
Lafayette RA. Facing the vexing problem of recurrent FSGS after kidney transplantation. Clin J Am Soc Nephrol. 2020;15(2):171–3. doi:.https://doi.org/10.2215/CJN.14841219
Levine AP, Chan MMY, Sadeghi-Alavijeh O, Wong EKS, Cook HT, Ashford S, et al.; MPGN/DDD/C3 Glomerulopathy Rare Disease Group; NIHR BioResource. Large-scale whole-genome sequencing reveals the genetic architecture of primary membranoproliferative GN and C3 glomerulopathy. J Am Soc Nephrol. 2020;31(2):365–73. doi:.https://doi.org/10.1681/ASN.2019040433
Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, et al. Use of highly individualized complement blockade has revolutionized clinical outcomes after kidney transplantation and renal epidemiology of atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2019;30(12):2449–63. doi:.https://doi.org/10.1681/ASN.2019040331